已收盘 11-07 16:00:00 美东时间
+0.300
+0.18%
Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.
11-05 21:26
Final trades on CNBC's Halftime Report: Vistra Corp. named top trade, PayPal CEO engineering turnaround, Netflix & Invesco QQQ Trust also mentioned.
10-29 19:47
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
10-29 09:25
①作为全球最具影响力的中央银行,美联储本周公布的最新利率决议,无疑将成为全球市场上万众瞩目的重头戏;②不过,从央行领域的财经日历看,美联储显然不会是接下来两天唯一的亮点……
10-29 08:39
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and raises the price target from $170 to $173.
10-28 23:29
On CNBC's "Halftime Report," two experts, Bryn Talkington and Jim Lebenthal, named Alphabet as their final trade.
10-28 19:51
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Virtus Inv (NASDAQ:VRTS) reported quarterly earnings of $6.69 per share which missed the analyst consensus estimate of $6.77 by 1.21 percent. This is a 3.32 percent decrease over earnings of $6.92 per share from the same
10-24 19:04
Companies Reporting Before The Bell • Eni (NYSE:E) is expected to report quarte...
10-24 16:32
Virtus Inv (NASDAQ:VRTS) is gearing up to announce its quarterly earnings on Fr...
10-23 23:03